연구동향 분석
박사

금식 후 운동 강도와 형태가 FGF21/Akt Pathway를 통한 대사 변인에 미치는 영향 = The effect of exercise intensity and type on metabolic variables via FGF21/Akt Pathway after fasting

이진석 2015년

논문상세정보
인용/피인용
' 금식 후 운동 강도와 형태가 FGF21/Akt Pathway를 통한 대사 변인에 미치는 영향 = The effect of exercise intensity and type on metabolic variables via FGF21/Akt Pathway after fasting' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • akt
  • exercise intensity
  • exercise type
  • fasting
  • fgf21
  • metabolic disorders
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
180 0

0.0%

' 금식 후 운동 강도와 형태가 FGF21/Akt Pathway를 통한 대사 변인에 미치는 영향 = The effect of exercise intensity and type on metabolic variables via FGF21/Akt Pathway after fasting' 의 참고문헌

  • 저항운동이 쥐의 지질대사관련 단백질 발현에 미치는 영향. 미간행 석사학위 논문
    안재흥 단국대학교 [2012]
  • 대사증후군의 위험요소를 가진 중년여성의 체중관리 프로그램의 효과
    김시화 박태선 변문선 유옥경 차연수 대한비만학회지. 23(2), 106-115 [2013]
  • de Lange, P., Farina, P., Moreno, M., Ragni, M., Lombardi, A., Silvestri, E., ... & Goglia, F. (2006). Sequential changes in the signal transduction responses of skeletal muscle following food deprivation. The FASEB Journal, 20(14), 2579-2581.
  • Zong, H., Ren, J. M., Young, L. H., Pypaert, M., Mu, J., Birnbaum, M. J., & Shulman, G. I. (2002). AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proceedings of the National Academy of Sciences, 99(25), 15983-15987.
  • Zimmet, P., Alberti, K. G. M., & R os, M. S. (2005). A new International Diabetes Federation (IDF) worldwide definition of the metabolic syndrome: the rationale and the results. Revista Espa ola de Cardiolog a (English Edition), 58(12), 1371-1375.
  • Zierath, J. R., Tsao, T. S., Stenbit, A. E., Ryder, J. W., Galuska, D., & Charron, M. J. (1998). Restoration of hypoxia-stimulated glucose uptake in GLUT4-deficient muscles by muscle-specific GLUT4 transgenic complementation. Journal of Biological Chemistry, 273(33), 20910-20915.
  • Zhang, X., Yeung, D. C., Karpisek, M., Stejskal, D., Zhou, Z. G., Liu, F., ... & Xu, A. (2008). Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes, 57(5), 1246-1253.
  • Zanchi, N. E., de Siqueira Filho, M. A., Lira, F. S., Rosa, J. C., Yamashita, A. S., de Oliveira Carvalho, C. R., ... & Lancha-Jr, A. H. (2009). Chronic resistance training decreases MuRF-1 and Atrogin-1 gene expression but does not modify Akt, GSK-3β and p70S6K levels in rats. European Journal of Applied Physiology, 106(3), 415-423.
  • Yang, S. J., Hong, H. C., Choi, H. Y., Yoo, H. J., Cho, G. J., Hwang, T. G., ... & Choi, K. M. (2011). Effects of a three‐month combined exercise programme on fibroblast growth factor 21 and fetuin‐A levels and arterial stiffness in obese women. Clinical Endocrinology, 75(4), 464-469.
  • Wu, J., Cohen, P., & Spiegelman, B. M. (2013). Adaptive thermogenesis in adipocytes: Is beige the new brown?. Genes and Development, 27(3), 234-250.
  • Woo, Y. C., Xu, A., Wang, Y., & Lam, K. S. (2013). Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives. Clinical Endocrinology, 78(4), 489-496.
  • Winder, W. W., Wilson, H. A., Hardie, D. G., Rasmussen, B. B., Hutber, C. A., Call, G. B., ... & Zhou, B. (1997). Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. Journal of Applied Physiology, 82(1), 219-225.
  • Winder, W. W. (2001). Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. Journal of Applied Physiology, 91(3), 1017-1028.
  • Wilson, P. W., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998). Prediction of coronary heart disease using risk factor categories. Circulation, 97(18), 1837-1847.
  • Wheless, J. W. (1995). The ketogenic diet: fa (c) t or fiction. Journal of Child Neurology, 10(6), 419-423.
  • Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001). Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. The Journal of Clinical Endocrinology and Metabolism, 86(5), 1930-1935.
  • Watkins, L. L., Sherwood, A., Feinglos, M., Hinderliter, A., Babyak, M., Gullette, E., ... & Blumenthal, J. A. (2003). Effects of exercise and weight loss on cardiac risk factors associated with syndrome X. Archives of Internal Medicine, 163(16), 1889-1895.
  • Ventura-Clapier, R., Mettauer, B., & Bigard, X. (2007). Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure. Cardiovascular Research, 73(1), 10-18.
  • Tremblay, F. & Marette, A. (2001). Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. Journal of Biological Chemistry, 276(41), 38052-38060.
  • Thio, L. L., Erbayat-Altay, E., Rensing, N., & Yamada, K. A. (2006). Leptin contributes to slower weight gain in juvenile rodents on a ketogenic diet. Pediatric Research, 60(4), 413-417.
  • Terada, S., Yamamoto, S., Sekine, S., & Aoyama, T. (2012). Dietary intake of medium-and long-chain triacylglycerols ameliorates insulin resistance in rats fed a high-fat diet. Nutrition, 28(1), 92-97.
  • Swink, T. D., Vining, E. P., & Freeman, J. M. (1996). The ketogenic diet: 1997. Advances in Pediatrics, 44, 297-329.
  • Swain, D. P. & Franklin, B. A. (2006). Comparison of cardioprotective benefits of vigorous versus moderate intensity aerobic exercise. The American Journal of Cardiology, 97(1), 141-147.
  • Stensvold, D., Tj nna, A. E., Skaug, E. A., Aspenes, S., St len, T., Wisl ff, U., & Sl rdahl, S. A. (2010). Strength training versus aerobic interval training to modify risk factors of metabolic syndrome. Journal of Applied Physiology, 108(4), 804-810.
  • Smutok, M. A., Reece, C., Kokkinos, P. F., Farmer, C., Dawson, P., Shulman, R., ... & Hurley, B. F. (1993). Aerobic versus strength training for risk factor intervention in middle-aged men at high risk for coronary heart disease. Metabolism, 42(2), 177-184.
  • Shubair, M. M., Kodis, J., McKelvie, R. S., Arthur, H. M., & Sharma, A. M. (2004). Metabolic profile and exercise capacity outcomes: their relationship to overweight and obesity in a Canadian cardiac rehabilitation setting. Journal of Cardiopulmonary Rehabilitation and Prevention, 24(6), 405-413.
  • Shapiro, M. E. (2001). Effects of treatment of C57BL/6j mice fed high vs. low fat diets with metformin or rosiglitazone on adiposity, food intake, hyperglycemia and insulin resistance. In Endocrine Society Annual Meeting.
  • Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., ... & Spiegelman, B. M. (2006). PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proceedings of the National Academy of Sciences, 103(44), 16260-16265.
  • Saha, A. K. & Ruderman, N. B. (2003). Malonyl-CoA and AMP-activated protein kinase: an expanding partnership. Molecular and Cellular Biochemistry, 253(1-2), 65-70.
  • Ruderman, N. B., Xu, X. J., Nelson, L., Cacicedo, J. M., Saha, A. K., Lan, F., &Ido, Y. (2010). AMPK and SIRT1: a long-standing partnership?. American Journal of Physiology-Endocrinology and Metabolism, 298(4), E751-E760.
  • Ruderman, N. B., Saha, A. K., Vavvas, D., & Witters, L. A. (1999). Malonyl-CoA, fuel sensing, and insulin resistance. American Journal of Physiology-Endocrinology and Metabolism, 276(1), E1-E18.
  • Rognmo, ., Moholdt, T., Bakken, H., Hole, T., M lstad, P., Myhr, N. E., ... & Wisl ff, U. (2012). Cardiovascular risk of high-versus moderate-intensity aerobic exercise in coronary heart disease patients. Circulation, 126(12), 1436-1440.
  • Ridker, P. M. (2003). Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 107(3), 363-369
  • Reznick, R. M., Zong, H., Li, J., Morino, K., Moore, I. K., Hannah, J. Y., ... & Shulman, G. I. (2007). Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metabolism, 5(2), 151-156.
  • Reitman, M. L. (2007). FGF21: a missing link in the biology of fasting. Cell Metabolism, 5(6), 405-407.
  • Reinehr, T., Woelfle, J., Wunsch, R., & Roth, C. L. (2012). Fibroblast growth factor 21 (FGF -21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. The Journal of Clinical Endocrinology and Metabolism, 97(6), 2143-2150.
  • Reaven, G. M. (1988). Role of insulin resistance in human disease. Diabetes, 37(12), 1595-1607.
  • Qiu, S. H., Sun, Z. L., Cai, X., Liu, L., & Yang, B. (2012). Improving patients' adherence to physical activity in diabetes mellitus: a review. Diabetes & Metabolism Journal, 36(1), 1-5.
  • Potthoff, M. J., Kliewer, S. A., & Mangelsdorf, D. J. (2012). Endocrine fibroblast growth factors 15/19 and 21: from feast to famine. Genes and Development, 26(4), 312-324.
  • Pedersen, B. K., Steensberg, A., & Schjerling, P. (2001). Exercise and interleukin-6. Current Opinion in Hematology, 8, 137-141.
  • Pate, R. R., Pratt, M., Blair, S. N., Haskell, W. L., Macera, C. A., Bouchard, C., ... &Wilmore, J. H. (1995). Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. Jama, 273(5), 402-407.
  • Palacios, O. M., Carmona, J. J., Michan, S., Chen, K. Y., Manabe, Y., Ward Iii, J. L., ... & Tong, Q. (2009). Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1α in skeletal muscle. Aging (Albany NY), 1(9), 771.
  • O’Conner, B., Simmons, J., & O’Shea, P.(1989). Weight training today. Saint Paul, MN: West Publisher, 201-204..
  • Ojuka, E. O. (2004). Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proceedings of the Nutrition Society, 63(02), 275-278.
  • Ohta, H., & Itoh, N. (2014). Roles of FGFs as adipokines in adipose tissue development, remodeling, and metabolism. Frontiers in Endocrinology, 5.
  • Nishimura, T., Nakatake, Y., Konishi, M., & Itoh, N. (2000). Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression, 1492(1), 203-206.
  • Nagashima, Y., Ohno, T., Ogawa, K., & Kuroshima, A. (1995). Effects of fasting and refeeding on some metabolic characteristics of rat brown adipose tissue. The Japanese Journal of Physiology, 45(4), 645-658.
  • Munch, I. C., Markussen, N. H., & Oritsland, N. A. (1993). Resting oxygen consumption in rats during food restriction, starvation and refeeding. Acta Physiologica Scandinavica, 148(3), 335-340.
  • Miura, T., Suzuki, W., Ishihara, E., Arai, I., Ishida, H., Seino, Y., & Tanigawa, K. (2001). Impairment of insulin-stimulated GLUT4 translocation in skeletal muscle and adipose tissue in the Tsumura Suzuki obese diabetic mouse: a new genetic animal model of type 2 diabetes. European Journal of Endocrinology, 145(6), 785-790.
  • Merrill, G. F., Kurth, E. J., Hardie, D. G., & Winder, W. W. (1997). AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. American Journal of Physiology-Endocrinology and Metabolism, 273(6), E1107-E1112.
  • Meigs, J. B. (2002). Epidemiology of the metabolic syndrome, 2002. The American Journal of Managed care, 8(11 Suppl), S283-92.
  • Mashili, F. L., Austin, R. L., Deshmukh, A. S., Fritz, T., Caidahl, K., Bergdahl, K., ... & Krook, A. (2011). Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes/Metabolism Research and Reviews, 27(3), 286-297.
  • Manzanero, S., Gelderblom, M., Magnus, T., & Arumugam, T. V. (2011). Calorie restriction and stroke. Exp Transl Stroke Med, 3(8).
  • Manore, M. M. (2013). Weight management in the performance athlete. In Nestl Nutr. Inst. Workshop Ser (Vol. 75, pp. 123-133).
  • Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996). cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adiposemost abundant gene transcript 1). Biochemical and Biophysical Research Communications, 221(2), 286-289.
  • Madarame, H., Neya, M., Ochi, E., Nakazato, K., Sato, Y., & IshiiI, N. (2008). Cross-Transfer Effects of Resistance Training with Blood Flow Restriction. Medicine and Science in Sports and Exercise, 40(2), 258–263.
  • Luo, L., Lu, A., Wang, Y., Hong, A., Chen, Y., Hu, J., ... & Qin, Z. H. (2013). Chronic resistance training activates autophagy and reduces apoptosis of muscle cells by modulating IGF-1 and its receptors, Akt/mTOR and Akt/FOXO3a signaling in aged rats. Experimental Gerontology, 48(4), 427-436.
  • Lee, J. S., Kim, C. G., Seo, T. B., Kim, H. G., & Yoon, S. J. (2015). Effects of 8-week combined training on body composition, isokinetic strength, and cardiovascular disease risk factors in older women. Aging Clinical and Experimental Research, 27, 179-186.
  • Lee, D. & Goldberg, A. L. (2013). SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth. Journal of Biological Chemistry, 288(42), 30515-30526.
  • Laaksonen, D. E., Lakka, H. M., Salonen, J. T., Niskanen, L. K., Rauramaa, R., &Lakka, T. A. (2002). Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes care, 25(9), 1612-1618.
  • L ger, B., Cartoni, R., Praz, M., Lamon, S., D riaz, O., Crettenand, A., ... & Russell, A. P. (2006). Akt signalling through GSK-3β, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. The Journal of Physiology, 576(3), 923-933.
  • Koo, S. H., Satoh, H., Herzig, S., Lee, C. H., Hedrick, S., Kulkarni, R., ... & Montminy, M. (2004). PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3. Nature Medicine, 10(5), 530-534.
  • Kochan, Z., Karbowska, J., & Świerczyński, J. (1997). Unusual increase of lipogenesis in rat white adipose tissue after multiple cycles of starvation-refeeding. Metabolism, 46(1), 10-17.
  • Kochan, Z., Goyke, E., Karbowska, J., Slominska, E., & Swierczynski, J. (2001). The decrease of rat postprandial plasma triacylglycerol concentration after multiple cycles of starvation-refeeding. Hormone and metabolic research= Hormon-und Stoffwechselforschung= Hormones et metabolisme, 33(1), 26-29.
  • Kliewer, S. A., & Mangelsdorf, D. J. (2010). Fibroblast growth factor 21: from pharmacology to physiology. The American Journal of Clinical Nutrition, 91(1), 254S-257S.
  • Kirwan, J. P., del Aguila, L. F., Hernandez, J. M., Williamson, D. L., O'Gorman, D. J., Lewis, R., & Krishnan, R. K. (2000). Regular exercise enhances insulin activation of IRS-1-associated PI3-kinase in human skeletal muscle. Journal of Applied Physiology, 88(2), 797-803.
  • Kim, K. H., Kim, S. H., Min, Y. K., Yang, H. M., Lee, J. B., & Lee, M. S. (2013). Acute exercise induces FGF21 expression in mice and in healthy humans. PloS One, 8(5), e63517.
  • Kim, K. H., Jeong, Y. T., Oh, H., Kim, S. H., Cho, J. M., Kim, Y. N., ... & Lee, M. S. (2013). Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nature Medicine, 19(1), 83-92.
  • Kharitonenkov, A., Wroblewski, V. J., Koester, A., Chen, Y. F., Clutinger, C. K., Tigno, X. T., ... & Etgen, G. J. (2007). The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology, 148(2), 774-781.
  • Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., ... & Shanafelt, A. B. (2005). FGF-21 as a novel metabolic regulator. Journal of Clinical Investigation, 115(6), 1627-1635.
  • Kershaw, E. E. & Flier, J. S. (2004). Adipose tissue as an endocrine organ. The Journal of Clinical Endocrinology & Metabolism, 89(6), 2548-2556.
  • Kennedy, A. R., Pissios, P., Otu, H., Xue, B., Asakura, K., Furukawa, N., ... & Maratos-Flier, E. (2007). A high-fat, ketogenic diet induces a unique metabolic state in mice. American Journal of Physiology-Endocrinology and Metabolism, 292(6), E1724-E1739.
  • Kemi, O. J., & Wisl ff, U. (2010). High‐Intensity Aerobic Exercise Training Improves the Heart in Health and Disease. Journal of Cardiopulmonary Rehabilitation and Prevention, 30(1), 2-11.
  • Kawanaka, K., Tabata, I., Katsuta, S., & Higuchi, M. (1997). Changes in insulin-stimulated glucose transport and GLUT-4 protein in rat skeletal muscle after training. Journal of Applied Physiology, 83(6), 2043-2047.
  • Kavazis, A. N., Smuder, A. J., & Powers, S. K. (2014). Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle. Journal of Applied Physiology, 117(3), 223-230.
  • Katzmarzyk, P. T., Leon, A. S., Wilmore, J. H., Skinner, J. S., Rao, D. C., Rankinen, T., & Bouchard, C. (2003). Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study. Medicine and Science in Sports and Exercise, 35(10), 1703-1709.
  • Kaplan, N. M. (1989). The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Archives of Internal Medicine, 149(7), 1514-1520.
  • Jurca, R. A. D. I. M., Lamonte, M. J., Church, T. S., Earnest, C. P., Fitzgerald, S. J., Barlow, C. E., ... & Blair, S. N. (2004). Associations of muscle strength and fitness with metabolic syndrome in men. Medicine and Science in Sports and Exercise, 36(8), 1301-1307.
  • Juge-Aubry, C. E., Henrichot, E., & Meier, C. A. (2005). Adipose tissue: a regulator of inflammation. Best Practice and Research Clinical Endocrinology and Metabolism, 19(4), 547-566.
  • Jornayvaz, F. R. & Shulman, G. I. (2010). Regulation of mitochondrial biogenesis. Essays Biochem, 47, 69-84.
  • Jen, K. L., Lu, H., Savona, L., Watkins, A., & Shaw, M. (1995). Long-term weight cycling reduces body weight and fat free mass, but not fat mass in female Wistar rats. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity, 19(10), 699-708.
  • Izumiya, Y., Bina, H. A., Ouchi, N., Akasaki, Y., Kharitonenkov, A., & Walsh, K. (2008). FGF21 is an Akt-regulated myokine. FEBS Letters, 582(27), 3805-3810.
  • Itoh, N. (2010). Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease. Cell and Tissue Research, 342(1), 1-11.
  • Isomaa, B. O., Almgren, P., Tuomi, T., Fors n, B., Lahti, K., Niss n, M., ... & Groop, L. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes care, 24(4), 683-689.
  • Irving, B. A., Davis, C. K., Brock, D. W., Weltman, J. Y., Swift, D., Barrett, E. J., ... & Weltman, A. (2008). Effect of exercise training intensity on abdominal visceral fat and body composition. Medicine and Science in Sports and Exercise, 40(11), 1863.
  • Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., ... & Kliewer, S. A. (2007). Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21. Cell Metabolism, 5(6), 415-425.
  • Hudson, M. B., Rahnert, J. A., Zheng, B., Woodworth-Hobbs, M. E., Franch, H. A., & Price, S. R. (2014). miR-182 attenuates atrophy-related gene expression by targeting FoxO3 in skeletal muscle. American Journal of Physiology-Cell Physiology, 307(4), C314-C319.
  • Hopkins, M., Blundell, J. E., & King, N. A. (2013). Individual variability in compensatory eating following acute exercise in overweight and obese women. British Journal of Sports Medicine, bjsports-2012.
  • Holland, W. L., Adams, A. C., Brozinick, J. T., Bui, H. H., Miyauchi, Y., Kusminski, C. M., ... & Scherer, P. E. (2013). An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metabolism, 17(5), 790-797.
  • Hojman, P., Pedersen, M., Nielsen, A. R., Krogh-Madsen, R., Yfanti, C., kerstrom, T., ... & Pedersen, B. K. (2009). Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes, 58(12), 2797-2801.
  • Hertz, R., Bishara-Shieban, J., & Bar-Tana, J. (1995). Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. Journal of Biological Chemistry, 270(22), 13470-13475.
  • Han, T. S., & Lean, M. E. (2011). Metabolic syndrome. Medicine, 39(1), 24-31.
  • Groop, L. & Orho-Melander, M. (2001). The dysmetabolic syndrome. Journal of Internal Medicine, 250(2), 105-120.
  • Gleeson, M., Nieman, D. C., & Pedersen, B. K. (2004). Exercise, nutrition and immune function. Journal of Sports Sciences, 22(1), 115-125.
  • Gaster, M., Staehr, P., Beck-Nielsen, H., Schr der, H. D., & Handberg, A. (2001). GLUT4 Is Reduced in Slow Muscle Fibers of Type 2 Diabetic Patients Is Insulin Resistance in Type 2 Diabetes a Slow, Type 1 Fiber Disease?. Diabetes, 50(6), 1324-1329.
  • G lman, C., Lund sen, T., Kharitonenkov, A., Bina, H. A., Eriksson, M., Hafstr m, I., ... & Rudling, M. (2008). The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARα activation in man. Cell Metabolism, 8(2), 169-174.
  • Fujimoto, W. Y., Abbate, S. L., Kahn, S. E., Hokansno, J. E., & Brunzell, J. D. (1994). The Visceral Adiposity Syndrome in Japanese‐American Men. Obesity Research, 2(4), 364-371.
  • Fruebis, J., Tsao, T. S., Javorschi, S., Ebbets-Reed, D., Erickson, M. R. S., Yen, F. T., ... & Lodish, H. F. (2001). Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proceedings of the National Academy of Sciences, 98(4), 2005-2010.
  • Friedman, J. E., Sherman, W. M., Reed, M. J., Eiton, C. W., & Dohm, G. L. (1990). Exercise training increases glucose transporter protein GLUT-4 in skeletal muscle of obese Zucker (fa/fa) rats. FEBS Letters, 268(1), 13-16.
  • Ford, E. S. (2003). The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis, 168(2), 351-358.
  • Fisher, F. M. & Maratos-Flier, E. (2013). Stress heats up the adipocyte. Nature Medicine, 19(1), 17-18.
  • Ernsberger, P. A. U. L., Koletsky, R. J., Baskin, J. S., & Collins, L. A. (1996). Consequences of weight cycling in obese spontaneously hypertensive rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 270(4), R864-R872.
  • Earnest, C. P., Johannsen, N. M., Swift, D. L., Gillison, F. B., Mikus, C. R., Lucia, A., ... & Church, T. S. (2014). Aerobic and strength training in concomitant metabolic syndrome and type 2 diabetes. Medicine and Science in Sports and Exercise, 46(7), 1293-1301.
  • Durante, P. E., Mustard, K. J., Park, S. H., Winder, W. W., & Hardie, D. G. (2002). Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles. American Journal of Physiology-Endocrinology and Metabolism, 283(1), E178-E186.
  • Dumortier, M., Brandou, F., Perez-Martin, A., Fedou, C., Mercier, J., & Brun, J. F. (2003). Low intensity endurance exercise targeted for lipid oxidation improves body composition and insulin sensitivity in patients with the metabolic syndrome. Diabetes and Metabolism, 29(5), 509-518.
  • Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996). The PPAR-leukotriene B~4 pathway to inflammation control. Nature, 384(6604), 39-43.
  • DeFronzo, R. A., & Ferrannini, E. (1991). Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14(3), 173-194.
  • De Sousa-Coelho, A. L., Relat, J., Hondares, E., P rez-Mart , A., Ribas, F., Villarroya, F., ... & Haro, D. (2013). FGF21 mediates the lipid metabolism response to amino acid starvation. Journal of Lipid Research, 54(7), 1786-1797.
  • Daugaard, J. R., Nielsen, J. N., Kristiansen, S., Andersen, J. L., Hargreaves, M., & Richter, E. A. (2000). Fiber type-specific expression of GLUT4 in human skeletal muscle: influence of exercise training. Diabetes, 49(7), 1092-1095.
  • Cuevas-Ramos, D., Almeda-Vald s, P., Meza-Arana, C. E., Brito-C rdova, G., G mez-P rez, F. J., Mehta, R., ... & Aguilar-Salinas, C. A. (2012). Exercise increases serum fibroblast growth factor 21 (FGF21) levels. PLoS One, 7(5), e38022.
  • Cox, J. H., Cortright, R. N., Dohm, G. L., & Houmard, J. A. (1999). Effect of aging on response to exercise training in humans: skeletal muscle GLUT-4 and insulin sensitivity. Journal of Applied Physiology, 86(6), 2019-2025.
  • Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., ... & Kharitonenkov, A. (2008). Fibroblast growth factor 21 corrects obesity in mice. Endocrinology, 149(12), 6018-6027.
  • Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., ... &Kahn, S. E. (2003). Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia, 46(4), 459-469.
  • Civitarese, A. E., Carling, S., Heilbronn, L. K., Hulver, M. H., Ukropcova, B., Deutsch, W. A., ... & Ravussin, E. (2007). Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Medicine, 4(3), e76.
  • Cicione, C., Degirolamo, C., & Moschetta, A. (2012). Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver. Hepatology, 56(6), 2404-2411.
  • Chen, Z. P., Stephens, T. J., Murthy, S., Canny, B. J., Hargreaves, M., Witters, L. A., ... & McConell, G. K. (2003). Effect of exercise intensity on skeletal muscle AMPK signaling in humans. Diabetes, 52(9), 2205-2212.
  • Chavez, A. O., Molina-Carrion, M., Abdul-Ghani, M. A., Folli, F., DeFronzo, R. A., & Tripathy, D. (2009). Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance. Diabetes Care, 32(8), 1542-1546.
  • Cauza, E., Hanusch-Enserer, U., Strasser, B., Ludvik, B., Metz-Schimmerl, S., Pacini, G., ... & Haber, P. (2005). The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus. Archives of Physical Medicine and Rehabilitation, 86(8), 1527-1533.
  • Castilho-Fernandes, A., de Almeida, D. C., Fontes, A. M., Melo, F. U. F., Pican o-Castro, V., Freitas, M. C., ... & Covas, D. T. (2011). Human hepatic stellate cell line (LX-2) exhibits characteristics of bone marrow-derived mesenchymal stem cells. Experimental and Molecular Pathology, 91(3), 664-672.
  • Cant , C., Jiang, L. Q., Deshmukh, A. S., Mataki, C., Coste, A., Lagouge, M., ... & Auwerx, J. (2010). Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metabolism, 11(3), 213-219.
  • Camus, J. P. (1966). Gout, diabetes, hyperlipemia: a metabolic trisyndrome. Revue du rhumatisme et des maladies ost o-articulaires, 33(1), 10.
  • Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H., & Sabatini, D. M. (1998). RAFT1 phosphorylation of the translational regulators p70S6 kinase and 4E-BP1. Proceedings of the National Academy of Sciences of the United States of America, 95(4), 1432-1437.
  • Brubaker, P. H., Kaminsky, L. A., & Whaley, M. H. (2002). Coronary artery disease: essentials of prevention and rehabilitation programs. Human Kinetics Publishers. Brunzell, J. D. & Hokanson, J. E. (1999). Dyslipidemia of central obesity and insulin resistance. Diabetes Care.
  • Bough, K. J. & Eagles, D. A. (1999). A Ketogenic Diet Increases the Resistance to Pentylenetetrazole‐Induced Seizures in the Rat. Epilepsia, 40(2), 138-143.
  • Bostr m, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., ... & Spiegelman, B. M. (2012). A PGC1-[agr]-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 481(7382), 463-468.
  • Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., ... & Yancopoulos, G. D. (2001). Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nature Cell Biology, 3(11), 1014-1019.
  • Bertoli, A., Di Daniele, N., Ceccobelli, M., Ficara, A., Girasoli, C., & De Lorenzo, A. (2003). Lipid profile, BMI, body fat distribution, and aerobic fitness in men with metabolic syndrome. Acta Diabetologica, 40(1), s130-s133.
  • Berglund, E. D., Kang, L., Lee-Young, R. S., Hasenour, C. M., Lustig, D. G., Lynes, S. E., ... & Wasserman, D. H. (2010). Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARα and FGF21 transcripts in vivo. American Journal of Physiology-Endocrinology and Metabolism, 299(4), E607-E614.
  • Bedford, T. G., Tipton, C. M., Wilson, N. C., Oppliger, R. A., & Gisolfi, C. V. (1979). Maximum oxygen consumption of rats and its changes with various experimental procedures. Journal of Applied Physiology, 47(6), 1278-1283.
  • Bateman, L. A., Slentz, C. A., Willis, L. H., Shields, A. T., Piner, L. W., Bales, C. W., ... & Kraus, W. E. (2011). Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise-STRRIDE-AT/RT). The American Journal of Cardiology, 108(6), 838-844.
  • Balducci, S., Zanuso, S., Nicolucci, A., Fernando, F., Cavallo, S., Cardelli, P., ... & Pugliese, G. (2010). Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutrition, Metabolism and Cardiovascular Diseases, 20(8), 608-617.
  • Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007). Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metabolism, 5(6), 426-437.
  • Badman, M. K., Kennedy, A. R., Adams, A. C., Pissios, P., & Maratos-Flier, E. (2009). A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss. American Journal of Physiology-Endocrinology and Metabolism, 297(5), E1197-E1204.
  • Baar, K., Wende, A. R., Jones, T. E., Marison, M., Nolte, L. A., Chen, M. A. Y., ... & Holloszy, J. O. (2002). Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. The FASEB Journal, 16(14), 1879-1886.
  • Asikainen, T. M., Miilunpalo, S., Kukkonen-Harjula, K., Nenonen, A., Pasanen, M., Rinne, M., ... & Vuori, I. (2003). Walking trials in postmenopausal women: effect of low doses of exercise and exercise fractionization on coronary risk factors. Scandinavian Journal of Medicine and Science in Sports, 13(5), 284-292.
  • Antonopoulos, S. (2002). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation, 106(3143), 3421.
  • American College of Sports Medicine (2013). ACSM's guidelines for exercise testing and prescription. Lippincott Williams & Wilkins.
  • Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006). Metabolic syndrome—a new worldwide definition. A consensus statement from the international diabetes federation. Diabetic Medicine, 23(5), 469-480.
  • Alberti, K. & Zimmet, P. F. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, (15), 539-53.
  • Albert, M. A., Glynn, R. J., Buring, J., & Ridker, P. M. (2004). C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). The American Journal of Cardiology, 93(10), 1238-1242.